ELAN
Elanco Animal Health·NYSE
--
--(--)
--
--(--)
3.33 / 10
Netural
Fundamental strength is poor, scoring only 3.3/10. Key concerns include a Days Sales Outstanding of 64.23, indicating slow receivable collection, and negative YoY revenue growth. Interest coverage is weak at 1.25, and several valuation metrics like Profit-MV and Net income-Revenue are negative, pointing to operational challenges. However, the Revenue-MV factor is positive, offering a minor offset. Overall, the fundamentals warrant caution.
Analysis Checks(7/10)
Revenue-MV
Value0.12
Score2/3
Weight16.63%
1M Return7.73%
Value0.12
Score2/3
Weight16.63%
1M Return7.73%
Days sales outstanding
Value64.23
Score2/3
Weight1.85%
1M Return1.10%
Value64.23
Score2/3
Weight1.85%
1M Return1.10%
Net income-Revenue
Value-0.17
Score2/3
Weight16.96%
1M Return8.45%
Value-0.17
Score2/3
Weight16.96%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value1.25
Score2/3
Weight-1.70%
1M Return-1.11%
Value1.25
Score2/3
Weight-1.70%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight12.10%
1M Return5.75%
Value-0.50
Score0/3
Weight12.10%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value4.45
Score1/3
Weight-1.24%
1M Return-0.79%
Value4.45
Score1/3
Weight-1.24%
1M Return-0.79%
Profit-MV
Value-1.47
Score2/3
Weight16.95%
1M Return8.45%
Value-1.47
Score2/3
Weight16.95%
1M Return8.45%
PB-ROE
Value-0.31
Score3/3
Weight22.98%
1M Return12.83%
Value-0.31
Score3/3
Weight22.98%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value4.45
Score1/3
Weight-1.20%
1M Return-0.76%
Value4.45
Score1/3
Weight-1.20%
1M Return-0.76%
Cash-MV
Value-0.03
Score2/3
Weight16.66%
1M Return8.41%
Value-0.03
Score2/3
Weight16.66%
1M Return8.41%
Revenue-MV
Value0.12
Score2/3
Weight16.63%
1M Return7.73%
Value0.12
Score2/3
Weight16.63%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value4.45
Score1/3
Weight-1.24%
1M Return-0.79%
Value4.45
Score1/3
Weight-1.24%
1M Return-0.79%
Days sales outstanding
Value64.23
Score2/3
Weight1.85%
1M Return1.10%
Value64.23
Score2/3
Weight1.85%
1M Return1.10%
Profit-MV
Value-1.47
Score2/3
Weight16.95%
1M Return8.45%
Value-1.47
Score2/3
Weight16.95%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.96%
1M Return8.45%
Value-0.17
Score2/3
Weight16.96%
1M Return8.45%
PB-ROE
Value-0.31
Score3/3
Weight22.98%
1M Return12.83%
Value-0.31
Score3/3
Weight22.98%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value1.25
Score2/3
Weight-1.70%
1M Return-1.11%
Value1.25
Score2/3
Weight-1.70%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value4.45
Score1/3
Weight-1.20%
1M Return-0.76%
Value4.45
Score1/3
Weight-1.20%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight12.10%
1M Return5.75%
Value-0.50
Score0/3
Weight12.10%
1M Return5.75%
Cash-MV
Value-0.03
Score2/3
Weight16.66%
1M Return8.41%
Value-0.03
Score2/3
Weight16.66%
1M Return8.41%
Is ELAN undervalued or overvalued?
- ELAN scores 3.33/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.69% ROE, 0.78% net margin, 28.85 P/E ratio, 1.86 P/B ratio, and -82.93% earnings growth, these metrics solidify its Netural investment rating.
